Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?

cancers epigenetics melanoma therapies

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Oct 2022
Historique:
received: 31 08 2022
revised: 27 09 2022
accepted: 29 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Epigenetic regulations, that comprise histone modifications and DNA methylation, are essential to processes as diverse as development and cancer. Among the histone post-translational modifications, lysine methylation represents one of the most important dynamic marks. Here, we focused on methyltransferases of the nuclear binding SET domain 1 (NSD) family, that catalyze the mono- and di-methylation of histone H3 lysine 36. We review the loss of function mutations of

Identifiants

pubmed: 36230787
pii: cancers14194865
doi: 10.3390/cancers14194865
pmc: PMC9563040
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Ligue Nationale Contre le Cancer
ID : NA
Organisme : French National Cancer Institute
ID : INCA-16070
Organisme : Fondation pour la Recherche Médicale
ID : FRM ARF201809006989
Organisme : Fondation de France
ID : 00120250/WB-2021-33281
Organisme : Inserm
ID : NA
Organisme : Melanoma Research Alliance Team Science award
ID : NIH R01 CA253977

Références

Am J Med Genet. 1996 Sep 6;64(4):588-93
pubmed: 8870927
Pathol Int. 2012 Nov;62(11):735-41
pubmed: 23121604
Oncogene. 2012 May 10;31(19):2461-70
pubmed: 21996743
Am J Hum Genet. 2003 Jan;72(1):132-43
pubmed: 12464997
J Pediatr. 1992 Apr;120(4 Pt 1):572-4
pubmed: 1552397
Nat Rev Genet. 2009 May;10(5):295-304
pubmed: 19308066
Mod Pathol. 2004 Dec;17(12):1539-44
pubmed: 15257316
Mol Cancer. 2020 Mar 4;19(1):52
pubmed: 32127003
Epigenomics. 2015 Aug;7(5):863-74
pubmed: 25942451
Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):
pubmed: 28193767
Lancet Oncol. 2018 May;19(5):586-587
pubmed: 29650364
Hum Mutat. 2011 Mar;32(3):292-8
pubmed: 21972110
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8295-8300
pubmed: 30967505
Curr Opin Genet Dev. 2005 Jun;15(3):227-33
pubmed: 15917196
Nucleic Acids Res. 2021 Jun 21;49(11):6281-6295
pubmed: 34107030
Oncotarget. 2017 Jul 22;8(44):76423-76431
pubmed: 29100322
Nat Commun. 2020 Jun 12;11(1):2807
pubmed: 32533074
Clin Epigenetics. 2020 Feb 10;12(1):24
pubmed: 32041674
Am J Med Genet C Semin Med Genet. 2013 May;163C(2):86-91
pubmed: 23592277
Nat Commun. 2017 Nov 24;8(1):1772
pubmed: 29176703
Genome Biol. 2016 Oct 3;17(1):205
pubmed: 27716309
Clin Genet. 2017 Jan;91(1):73-78
pubmed: 27172843
Cell Rep. 2017 Jul 25;20(4):854-867
pubmed: 28746871
Nature. 2001 Nov 15;414(6861):277-83
pubmed: 11713521
PLoS One. 2012;7(11):e49229
pubmed: 23155469
Nat Commun. 2015 Jan 22;6:6051
pubmed: 25609585
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1886-91
pubmed: 19181860
Front Biosci. 2006 Jan 01;11:733-42
pubmed: 16146765
J Pediatr Hematol Oncol. 2004 Mar;26(3):204-8
pubmed: 15125616
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626742
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16952-7
pubmed: 20837538
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21830-5
pubmed: 20018718
J Cell Sci. 2003 Jun 1;116(Pt 11):2117-24
pubmed: 12730288
Radiol Case Rep. 2015 Nov 06;5(1):384
pubmed: 27307854
Mol Cell Biol. 2005 Nov;25(21):9447-59
pubmed: 16227595
Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S4-11
pubmed: 16341240
BMC Struct Biol. 2014 Dec 12;14:25
pubmed: 25494638
J Biol Chem. 2011 Mar 11;286(10):8361-8368
pubmed: 21196496
Oncogene. 2004 Jul 1;23(30):5215-26
pubmed: 15133491
Nat Commun. 2015 Dec 22;6:10207
pubmed: 26690673
Acta Biochim Biophys Sin (Shanghai). 2012 Jan;44(1):14-27
pubmed: 22194010
Cell Mol Life Sci. 2017 Sep;74(18):3317-3334
pubmed: 28386724
Cancer Res. 2015 Feb 15;75(4):628-34
pubmed: 25634215
Handb Clin Neurol. 2018;147:43-58
pubmed: 29325627
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2730-5
pubmed: 21482774
Cancers Head Neck. 2019 Jul 08;4:3
pubmed: 31321084
Nat Genet. 2017 Feb;49(2):180-185
pubmed: 28067913
Hum Mol Genet. 2022 Jul 7;31(13):2164-2184
pubmed: 35094088
Prog Retin Eye Res. 2021 Nov;85:100968
pubmed: 33852963
Protein Sci. 2016 May;25(5):1021-9
pubmed: 26940890
Cell Rep. 2015 Mar 10;10(9):1585-1598
pubmed: 25753423
PeerJ. 2019 Feb 06;7:e6396
pubmed: 30755832
Cell Biochem Funct. 2019 Jan;37(1):21-30
pubmed: 30604499
Cancer Res. 2017 Sep 15;77(18):4835-4845
pubmed: 28754676
EMBO J. 2003 Jun 16;22(12):3153-63
pubmed: 12805229
Pediatr Neurol. 2009 May;40(5):357-64
pubmed: 19380072
J Biol Chem. 2011 Mar 11;286(10):7983-7989
pubmed: 21239496
Nat Cell Biol. 2007 Jul;9(7):804-12
pubmed: 17589499
Cell. 2007 May 18;129(4):823-37
pubmed: 17512414
Pharmacol Res. 2021 Nov;173:105888
pubmed: 34536546
J Clin Oncol. 2006 Jan 10;24(2):268-73
pubmed: 16330673
Future Med Chem. 2016 Sep;8(13):1589-607
pubmed: 27548565
N Engl J Med. 1964 Jul 16;271:109-16
pubmed: 14148233
Genome Biol. 2019 Aug 14;20(1):146
pubmed: 31409373
Nature. 2019 Sep;573(7773):281-286
pubmed: 31485078
Mol Cell. 2007 Feb 9;25(3):473-81
pubmed: 17289593
Trends Biochem Sci. 1991 Dec;16(12):478-81
pubmed: 1664152
Epigenetics. 2018;13(7):683-692
pubmed: 30045670
Mol Cell. 2018 Apr 19;70(2):371-379.e5
pubmed: 29606589
Hum Mol Genet. 2005 Feb 15;14(4):535-42
pubmed: 15640245
Nat Chem Biol. 2020 Dec;16(12):1403-1410
pubmed: 32868895
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):132-143
pubmed: 29332125
Cell. 2018 Aug 9;174(4):843-855.e19
pubmed: 30017245
Infect Agent Cancer. 2021 Feb 15;16(1):13
pubmed: 33588906
Br J Cancer. 2004 Feb 23;90(4):761-9
pubmed: 14970850
Cancer Cell. 2021 May 10;39(5):610-631
pubmed: 33545064
J Exp Clin Cancer Res. 2019 Nov 14;38(1):467
pubmed: 31727171
Nat Cell Biol. 2019 Nov;21(11):1449-1461
pubmed: 31659274
Nat Genet. 2002 Apr;30(4):365-6
pubmed: 11896389
Genes Dev. 2017 Apr 15;31(8):724-743
pubmed: 28512236
J Biol Chem. 2001 Nov 2;276(44):40417-23
pubmed: 11509567
Life (Basel). 2021 Aug 25;11(9):
pubmed: 34575025
Blood. 2020 Jul 23;136(4):387-400
pubmed: 32344427
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
PLoS One. 2012;7(9):e44800
pubmed: 22984562
Mol Cell Biol. 1999 Jan;19(1):764-76
pubmed: 9858599
Cell Rep. 2021 Feb 23;34(8):108769
pubmed: 33626351
Gene. 2001 Nov 28;279(2):197-204
pubmed: 11733144
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Sci Rep. 2017 Dec 6;7(1):17064
pubmed: 29213088
Nat Rev Mol Cell Biol. 2012 Jan 23;13(2):115-26
pubmed: 22266761
Mol Cell. 2022 Jul 7;82(13):2472-2489.e8
pubmed: 35537449
J Biol Chem. 2016 Apr 15;291(16):8465-74
pubmed: 26912663
Theranostics. 2020 Jan 1;10(4):1777-1797
pubmed: 32042336
Oncogene. 2011 May 19;30(20):2307-18
pubmed: 21278797
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):46-51
pubmed: 20080798
Oncotarget. 2015 Sep 29;6(29):27023-36
pubmed: 26304929
Cell Chem Biol. 2016 Sep 22;23(9):1067-1076
pubmed: 27569753
Oncotarget. 2016 Aug 2;7(31):50719-50734
pubmed: 27191891
Curr Opin Psychiatry. 2019 Mar;32(2):55-59
pubmed: 30601169
Cell Death Differ. 2021 Jun;28(6):1990-2000
pubmed: 33462406

Auteurs

Imène Krossa (I)

Université Côte d'Azur, 06100 Nice, France.
Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France.

Thomas Strub (T)

Université Côte d'Azur, 06100 Nice, France.
Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France.

Andrew E Aplin (AE)

Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Robert Ballotti (R)

Université Côte d'Azur, 06100 Nice, France.
Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France.

Corine Bertolotto (C)

Université Côte d'Azur, 06100 Nice, France.
Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France.

Classifications MeSH